Health Care & Life Sciences » Biotechnology | BELLUS Health Inc.

BELLUS Health Inc. | Income Statement

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,256.00
2,376.00
4,024.00
1,893.00
165.00
35
SG&A Expense
5,545.00
4,845.00
4,415.00
4,139.00
6,139.00
10,594
EBIT
3,289.00
2,469.00
391.00
2,246.00
5,974.00
10,559
Unusual Expense
2,171.00
203.00
-
34.00
-
81
Non Operating Income/Expense
87.00
155.00
350.00
171.00
3,803.00
384
Interest Expense
142.00
104.00
11.00
11.00
11.00
5
Pretax Income
971.00
2,017.00
93.00
2,362.00
2,102.00
9,737
Income Tax
-
49.00
312.00
134.00
228.00
653
Consolidated Net Income
971.00
1,968.00
405.00
2,228.00
1,874.00
9,084
Net Income
872.00
1,931.00
202.00
2,159.00
1,874.00
9,084
Net Income After Extraordinaries
872.00
1,931.00
202.00
2,159.00
1,874.00
9,084
Net Income Available to Common
872.00
1,931.00
202.00
2,159.00
1,874.00
9,084
EPS (Basic)
0.02
0.04
0.00
0.04
0.03
0.08
Basic Shares Outstanding
47,426.40
47,426.40
47,426.40
58,391.70
68,667.80
121,020.70
EPS (Diluted)
0.02
0.04
0.00
0.04
0.03
0.08
Diluted Shares Outstanding
47,426.40
47,426.40
47,426.40
58,391.70
68,667.80
121,020.70
EBITDA
3,289.00
-
391.00
2,246.00
5,974.00
10,559
Non-Operating Interest Income
202.00
198.00
145.00
100.00
80.00
362
Minority Interest Expense
99.00
37.00
203.00
69.00
-
-

About BELLUS Health

View Profile
Address
275 Armand-Frappier boulevard
Laval Québec H7V 4A7
Canada
Employees -
Website http://www.bellushealth.com
Updated 07/08/2019
BELLUS Health, Inc. is a biopharmaceutical development company, which engages in the research and development of products that provide health solutions and address critical unmet medical needs. Its products include BLU-5937, KIACTA, AMO-01, and ALZ-801. The company was founded on April 12, 2012 and is headquartered in Laval, Canada.